Ovestinon
Brand of vaginal estriol authorised in Spain, indicated for the symptoms of vaginal atrophy caused by oestrogen deficiency in postmenopausal women. Its summary of product characteristics describes an initial regimen of one pessary daily for up to 4 weeks, followed by maintenance with one pessary twice weekly.
Institutional endorsement by Clínica Evolution
This entry is for information. Your case requires an individual medical assessment.